These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8549382)

  • 21. [Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
    MMW Fortschr Med; 2004 Mar; 146(11):56. PubMed ID: 15152775
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of ofloxacin in lower respiratory tract infections.
    Kobayashi H
    Infection; 1986; 14 Suppl 4():S279-82. PubMed ID: 3469163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy.
    Seki M; Sakata T; Toyokawa M; Nishi I; Tomono K
    Intern Med; 2016; 55(3):307-10. PubMed ID: 26831030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.
    Harazim H; Wimmer J; Mittermayer HP
    Drugs; 1987; 34 Suppl 1():71-3. PubMed ID: 3481331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of levofloxacin for the empirical treatment of exacerbations of mild, chronic COPD: Is it justified in under-65-years-old patients with no comorbidity?].
    Roig J; Martínez Benazet J; Casal J
    Arch Bronconeumol; 2002 Nov; 38(11):547; author reply 547-8. PubMed ID: 12435323
    [No Abstract]   [Full Text] [Related]  

  • 26. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of a new antibacterial agent, xibornol, in the treatment of bacterial infections of the upper respiratory tract in childhood. Comparison with erythromycin].
    Capristo AF; Maiello N; Coppola T; Decimo F; Miraglia del Giudice M; Antignani RG
    Minerva Pediatr; 1986 Jun; 38(11-12):503-10. PubMed ID: 3526110
    [No Abstract]   [Full Text] [Related]  

  • 28. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections.
    Lipsky BA; Tack KJ; Kuo CC; Wang SP; Grayston JT
    Am J Med; 1990 Dec; 89(6):722-4. PubMed ID: 2252040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gyrase inhibitor in pneumology. Ofloxacin--a new broad spectrum antibiotic in acute and chronic respiratory tract infections].
    Rubin AR
    Prax Klin Pneumol; 1985 Oct; 39(10):360-1. PubMed ID: 2999748
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnosis and treatment of bacterial infections of the lower respiratory tract. Comparative study: Tibirox versus erythromycin].
    Petite J
    Schweiz Rundsch Med Prax; 1982 Nov; 71(47):1860-5. PubMed ID: 6760172
    [No Abstract]   [Full Text] [Related]  

  • 32. [On some characteristics of staphylococci isolated from the sputum before and after therapy with erythromycin].
    Lo Curto RB; Pernice A; Alonzo V
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):269-75. PubMed ID: 4802277
    [No Abstract]   [Full Text] [Related]  

  • 33. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 65-year-old woman with acute cough illness and an important engagement.
    Gonzales R
    JAMA; 2003 May; 289(20):2701-8. PubMed ID: 12771117
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease.
    Maesen FP; Davies BI; Baur C; Sumajow CA
    J Antimicrob Chemother; 1986 Nov; 18(5):629-34. PubMed ID: 3468098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ten-year experience with the use of ofloxacin (Tarivid*). New treatment regimens].
    Navashin SM; Navashin PS; Smirnova LB
    Antibiot Khimioter; 1996; 41(9):99-103. PubMed ID: 9005800
    [No Abstract]   [Full Text] [Related]  

  • 37. Overview of experience with ofloxacin in respiratory tract infection.
    Ball P
    Scand J Infect Dis Suppl; 1990; 68():56-63. PubMed ID: 2218424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of ofloxacin in the treatment of lower respiratory tract infections in general practice.
    Moorhouse EC; Clarke PC
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():135-8. PubMed ID: 3182455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
    Ramos FL; Criner GJ
    Curr Opin Pulm Med; 2014 Mar; 20(2):153-8. PubMed ID: 24378875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment in general practice. Effective, well tolerated therapy].
    MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.